species: Homo sapiens studyId: syn51133946 studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial accessType: PRIVATE fileFormat: bam initiative: DHART-SPORE Project 3 isCellLine: No dataSubtype: raw individualID: HM5075 resourceType: experimentalData fundingAgency: NIH-NCI isMultiSpecimen: No isMultiIndividual: No
Drop files to upload
57890252_HM5075_0000281C0L.normal.abra.bam page is loading…